VARIABLENAME,VARIABLELABEL,VARTYPE,UNITS,CATEGORICAL,Missing,COUNT,NA,MIN,MAX,Definition,Formula,Categorical Value Concept Code,Categorical Value Concept Name,Categorical Value OMOP ID,Variable Concept Name,Variable Concept Code,Variable OMOP ID,Additional Context Concept Name,Additional Context Concept Code,Additional Context OMOP ID,Unit Concept Name,Unit Concept Code,Unit OMOP ID,Domain,Visits,Visit OMOP ID,Visit Concept Name,Visit Concept Code
N_A,exacerbation of heart failure,int,,1=yes|0=no,,11332,,0,1,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,exacerbation of heart failure,omop:OMOP5166003,1340348,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
DosisfrequentieACE,Angiotensin-Converting Enzyme inhibitors: daily frequency,int,,1=once a day|2=twice a day|3=three times a day,9999,11332,,1,9999,,,na|loinc:LA13827-3|loinc:LA13840-6|loinc:LA13851-3,na|1 time per day|2 times per day|3 times per day,na|45885250|45883167|45883169,"""ACE inhibitors, plain""",atc:C09AA,21601784,Dosage|frequency per day,snomed:260911001|snomed:307438009,4118853|4145077,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DagdosisStatines,statin:total daily dosage,int,mg (miligram),,,11332,,0,9999,,,,,,hmg-coa reductase inhibitor,atc:C10AA,21601855,Dosage|frequency per day,snomed:260911001|snomed:307438009,4118853|4145077,milligram,ucum:mg,8576,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
Ischemiedetectie_dsestressecho,Dobutamine Stress Echocardiography (DSE) is performed for ischemia detection,str,,1=yes|0=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,stress echocardiography using dobutamine,snomed:703338002,45773079,ischemia,snomed:52674009,4200991,,,,procedure_occurrence,baseline,40766819,Baseline time,loinc:64103-5
RAS,Renin-angiotensin system (RAS):Medication administered,int,,1=yes|0=no,,11332,,0,1,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Renin-inhibitors,atc:C09XA,21601849,,,,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
Geslacht,patient sex,str,,man=male|vrouw=female,,11332,,,,,,loinc:LA2-8|loinc:LA3-6,male|female,45880669|45878463,Sex assigned at birth,loinc:76689-9,46235213,,,,,,,person,baseline,40766819,Baseline time,loinc:64103-5
HFREFsystHF,heart failure with reduced ejection fraction (HFrEF) or Systolic Heart Failure,str,,1=yes|0=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,heart failure with reduced ejection fraction,snomed:703272007,45766164,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
PatiÃ«ntnummer,Patient hospital number,int,,,,11332,,1,11332,,,,,,patient hospital number,snomed:184107009,4086934,,,,,,,person,baseline,40766819,Baseline time,loinc:64103-5
Select,Patient entered into trial: heart failure,int,,1=yes|0=no,,11332,,0,1,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,patient entered into trial,snomed:185923000,4090379,heart failure,loinc:LP269425-7,1177390,,,,observation,baseline,40766819,Baseline time,loinc:64103-5
Leeftijd,Age,int,Years,,,11332,,18,103,,,,,,age,snomed:397669002,4265453,,,,year,ucum:a,9448,measurement,baseline,40766819,Baseline time,loinc:64103-5
Gewichtkg,Body weight,int,kg,,,11332,,29,180,,,,,,body weight,loinc:29463-7,3025315,,,,kilogram,ucum:kg,9529,measurement,baseline,40766819,Baseline time,loinc:64103-5
Lengtecm,Body height,int,cm,,,11332,,126,205,,,,,,body height,loinc:BDYHGT,45876161,,,,centimeter,ucum:cm,8582,measurement,baseline,40766819,Baseline time,loinc:64103-5
HFpEF,heart failure with preserved ejection fraction (HFpEF),int,,1=yes|0=no,,11332,,0,1,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,heart failure with normal ejection fraction,snomed:446221000,40486933,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
BMI,Body Mass Index,int,,,,11332,,14,61,,kg/m2,,,,body mass index (bmi) [ratio],loinc:39156-5,3038553,,,,kilogram per square meter,ucum:kg/m2,9531,measurement,baseline,40766819,Baseline time,loinc:64103-5
Hartfalenpoli,Patient entered into trial: heart failure,str,,1=yes|0=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8|snomed:9130008,yes|no|previous,45877994|45878245|4238439,patient entered into trial,snomed:185923000,4090379,heart failure,loinc:LP269425-7,1177390,,,,observation,baseline,40766819,Baseline time,loinc:64103-5
PulsPressure,Pulse pressure,int,mmHg,,,11332,,8,160,,,,,,arterial pulse pressure,snomed:87179004,4314539,pulse,snomed:8499008,4224504,millimeter mercury column,ucum:mm[Hg],8876,measurement,baseline,40766819,Baseline time,loinc:64103-5
BDsyst,Systolic blood pressure,int,mmHg,,,11332,,65,231,,,,,,systolic blood pressure,loinc:8480-6,3004249,,,,millimeter mercury column,ucum:mm[Hg],8876,measurement,baseline,40766819,Baseline time,loinc:64103-5
BDdiast,diastolic blood pressure,int,mmHg,,,11332,,30,148,,,,,,diastolic blood pressure,loinc:8462-4,3012888,,,,millimeter mercury column,ucum:mm[Hg],8876,measurement,baseline,40766819,Baseline time,loinc:64103-5
Oedeem,edema,str,,1=yes|0=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,edema,snomed:267038008,433595,,,,,,,observation,baseline,40766819,Baseline time,loinc:64103-5
Vulling,blood volume finding,str,,normo volemisch=a normal volume of blood in the body|hyper volemisch=fluid overload|hypo volemisch=volume depletion or volume contraction,,11332,,,,,,snomed:64826008|snomed:21639008|snomed:816082000,normal blood volume|hypervolemia|hypovolemia,4276680|434004|37311319,blood volume,snomed:16086006,4053108,,,,,,,measurement,baseline,40766819,Baseline time,loinc:64103-5
HFPEFdiasHF,heart failure with preserved ejection fraction (HFpEF) or Diastolic heart failure,str,,1=yes|0=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,heart failure with normal ejection fraction,snomed:446221000,40486933,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
HFrEF,heart failure with reduced ejection fraction,int,,1=yes|0=no,,11332,,0,1,,,snomed:52101004|snomed:2667000,present|absent,4181412|4132135,heart failure with reduced ejection fraction,snomed:703272007,45766164,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
EFBegin,Ejection fraction in the beginning of a treatment,int,,,,11332,,5,80,,,,,,cardiac ejection fraction,snomed:70822001,4323433,baseline time,loinc:64103-5,40766819,,,,measurement,baseline,40766819,Baseline time,loinc:64103-5
EFNu,Ejection fraction during treatment,int,,,,11332,,5,80,,,,,,cardiac ejection fraction,snomed:70822001,4323433,follow-up,loinc:LA9177-2,45880098,,,,measurement,baseline,40766819,Baseline time,loinc:64103-5
TIgradient,Tricuspid atrioventricular gradient,str,MmHg,<30mmHg=Tricuspid Atrioventricular Gradient <30 mmHg|>30mmHg=Tricuspid Atrioventricular Gradient >30 mmHg|30mmHg=Tricuspid Atrioventricular Gradient =30 mmHg,,11332,,,,,,loinc:LA33166-2|snomed:264717004|snomed:264711003,little or < 5 mm|40mm|30mm,1762620|4131984|4131982,tricuspid atrioventricular gradient,snomed:251083001,4108721,,,,millimeter mercury column,ucum:mm[Hg],8876,measurement,baseline,40766819,Baseline time,loinc:64103-5
DiastolischLVfunctierestrictief,Left ventricular diastolic dysfunction,str,,1=yes|0=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,left ventricular diastolic dysfunction,snomed:395704004,4212798,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
VenaCavaInferiordiameter,Inferior vena cava Diameter by US,str,mm,15-25mm=Inferior vena cava Diameter between at 15 and 25| <15mm=Inferior vena cava Diameter less than 15| >25mm=Inferior vena cava Diameter more than 25,,11332,,,,,,,,,inferior vena cava diameter by us,loinc:18006-7,3005557,,,,millimeter,ucum:mm,8588,measurement,baseline,40766819,Baseline time,loinc:64103-5
VCICollaps,collapse of vena cava,str,,>50%=more than 50%| <50%=less than 50| 100%=full,,11332,,,,,,loinc:LA15534-3|loinc:LA15691-1|loinc:LA15253-0,more than 50% of the time|<50|100%,45883625|45883438|45883548,obstruction of superior vena cava,snomed:766949003,35624289,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
RVfalen,Right Ventricular Failure finding,str,,1=yes|0=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Right ventricular failure,snomed:367363000,4273632,,,,,,,observation,baseline,40766819,Baseline time,loinc:64103-5
NYHA,New York Heart Association classification that range from I:(no limitation) to IV:(severe limitation),str,, NYHA I=new york heart failure class 1|NYHA II=new york heart failure class 2| NYHA III=new york heart failure class 3| NYHA IV=new york heart failure class 4,,11332,,,,,,snomed:420300004| snomed:421704003| snomed:420913000| snomed:422293003,New York Heart Association Classification - Class I| New York Heart Association Classification - Class II| New York Heart Association Classification - Class III| New York Heart Association Classification - Class IV,4220607|4226789|4227345|4228881,new york heart association classification,snomed:420816009,4223299,,,,,,,measurement,baseline,40766819,Baseline time,loinc:64103-5
Stabiel,Patient's condition stable:finding,str,,1=yes|0=no,,11332,,,,,,snomed:58158008|loinc:LA14123-6,stable|unstable,4241442|45883034,patient's condition stable,snomed:359746009,4234874,patient,loinc:LA4634-7,45880001,,,,observation,baseline,40766819,Baseline time,loinc:64103-5
Redeninstabiel,reason of patient's unstable condition,str,,,,11332,,,,,,,,,patient's condition unstable,snomed:162668006,4037288,patient condition finding,snomed:418138009,4167037,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Rusthartfrequentie,Resting heart rate,int,beats per minute,,,11332,,33,180,,,,,,resting heart rate,snomed:444981005,40481601,,,,counts per minute,{counts}/min,8483,measurement,baseline,40766819,Baseline time,loinc:64103-5
Ritme,Cardiac Rhythm diagnosed,str,,"Sinusritme=Sinus Rhythm|AF permanent=Permanent Atrial Fibrillation|Pacemaker ritme=Pacemaker Rhythm|AF persisterend=Persistent Atrial Fibrillation|AF maar type onbekend=Atrial Fibrillation, type unknown|AF paroxysmaal=Paroxysmal Atrial Fibrillation|Ectopisch=Ectopic Rhythm",,11332,,,,,,snomed:251150006|snomed:440028005|snomed:10370003|snomed:440059007|snomed:49436004|snomed:282825002|snomed:29320008,sinus rhythm|permanent atrial fibrillation|rhythm from artificial pacing|persistent atrial fibrillation|atrial fibrillation|paroxysmal atrial fibrillation|ectopic rhythm,4091898|4232691|4304202|4232697|313217|4154290|4164083,cardiac arrhythmia,snomed:698247007,44784217,cardiac rhythm type,snomed:251149006,4091457,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Ectopischritme,Type of Ectopic Rhythm diagnosed,str,,,,11332,,,,,,,,,ectopic rhythm,snomed:29320008,4164083,cardiac arrhythmia,snomed:698247007,44784217,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Geleidingsstoornissen2,conduction system disorder,str,,LBTB=Left Bundle Branch Block|geleidingsvertraging=Conduction Delay|1e graads AV blok=First-degree AV Block|3e graads AV blok=Third-degree AV Block|Gecombineerde geleidingsstoornis=Combined Conduction Disorder|Bifasciculair blok=Bifascicular Block|2e graads AV blok=Second-degree AV Block|Trifasciculair blok=Trifascicular Block,,11332,,,,,,snomed:63467002|snomed:698252002|loinc:LA17086-2|loinc:LA17089-6|snomed:44808001|snomed:74021003|snomed:195042002|snomed:86014007,left bundle branch block|non-specific intraventricular conduction delay|av block-1st degree|av block-3rd degree|conduction disorder of the heart|bifascicular block|second degree atrioventricular block|trifascicular block,316998|44784220|45884784|45884786|316999|4250169|318448|321315,conduction disorder of the heart,snomed:44808001,316999,,,,,,,measurement,baseline,40766819,Baseline time,loinc:64103-5
Geleidingsstoornissen1,conduction system disorder,str,,Geen geleidingsstoornis=No Conduction Disorder|Ventriculaire geleidingsstoornis=Ventricular Conduction Disorder|AV geleidingsstoornis=AV Conduction Disorder|SA-blok=Sinoatrial Block|Gecombineerde geleidingsstoornis=Combined Conduction Disorder,,11332,,,,,,snomed:44808001|snomed:418341009|snomed:418341009|snomed:65778007|snomed:44808001,conduction disorder of the heart|atrioventricular conduction disorder|atrioventricular conduction disorder|sinoatrial block|conduction disorder of the heart,316999|4305210|4305210|4277903|316999,conduction disorder of the heart,snomed:44808001,316999,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
LBTB,Left Bundle Branch Block(LBBB) disorder,str,,1=yes|0=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,left bundle branch block,snomed:63467002,316998,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
RBTB,Right Bundle Branch Block(RBBB) disorder,str,,1=yes|0=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,right bundle branch block,snomed:59118001,314059,conduction disorder of the heart,snomed:44808001,316999,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
QRS_2,QRS terminal amplitude in lead V2,int,,,,11332,,60,256,,,,,,qrs terminal amplitude in lead v2,loinc:9980-4,3024346,,,,,,,measurement,baseline,40766819,Baseline time,loinc:64103-5
CreatineumolL,Creatinine level in micromoles per liter,int,umol/L,,,11332,,3.8,9102,,,,,,creatinine [mass/volume] in serum or plasma,loinc:2160-0,3016723,,,,micromole per liter,ucum:umol/L,8749,measurement,baseline,40766819,Baseline time,loinc:64103-5
eGFR,estimated glomerular filtration rate,float,mL/min/(173.10*-2.m2),,,11332,,2.36,151.06,,,,,,Estimated creatinine clearance calculated using actual body weight Cockcroft-Gault formula,Snomed:1556501000000100,37169169,,,,milliliter per minute per 1.73 square meter,ucum:mL/min/(173.10*-2.m2),720870,measurement,baseline,40766819,Baseline time,loinc:64103-5
KaliummmolL,Potassium level in micromoles per liter,str,umol/L,,,11332,,,,,,,,,Potassium [Moles/volume] in Blood,Loinc:6298-4,3005456,,,,micromole per liter,ucum:umol/L,8749,measurement,baseline,40766819,Baseline time,loinc:64103-5
Maligniteit,malignant neoplasm,str,,1=yes|0=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,malignant neoplasm,snomed:1240414004,37153816,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Polygrafie,polysomnography performed,str,,1=yes|0=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,polysomnography,snomed:60554003,4189015,,,,,,,procedure_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Vochtbeperking,fluid intake restrictions,str,,1=yes|0=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,fluid restriction,snomed:25389001,4103309,,,,,,,procedure_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Natriumbeperking,sodium chloride intake restrictions,str,,1=yes|0=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,chloride salt intake,snomed:1148944005,602964,restricted,snomed:263856008,4137826,,,,measurement,baseline,40766819,Baseline time,loinc:64103-5
Antistolling,anticoagulation (blood-thinning) therapy,str,,OAC=Oral Anticoagulant|Tromb aggregatie remmers=Antiplatelet Drugs|DAPT=Dual Antiplatelet Therapy|nvt=Not applicable|NOAC=Non-vitamin K Oral Anticoagulant (DOAC)|OAC + tromb aggregatieremmer=OAC+Antiplatelet|TAPT=Triple Antiplatelet Therapy|Contraindicatie=Contraindicated|Gestopt ivm bijwerkingen=Discontinued due to side effects|OAC DAPT=OAC+DAPT|NOAC + tromb aggregatie remmer=NOAC+Antiplatelet|NOAC + DAPT=NOAC+DAPT|OAC NOAC=Both OAC and NOAC,,11332,,,,,,icare:icv200000075|snomed:771451006|icare:icv200000070|snomed:385432009|icare:icv200000071|icare:icv200000072|icare:icv200000073|snomed:410536001|snomed:395009001|icare:icv200000074|icare:icv200000076|icare:icv200000077|icare:icv200000078,oral anticoagulants|platelet aggregation inhibitor|dual antiplatelet therapy|not applicable|non-vitamin K antagonist oral anticoagulants|oral anticoagulants and antiplatelet drugs|triple antiplatelet therapy|contraindicated|medication stopped - side effect|oral anticoagulation and dual antiplatelet therapy|non-vitamin K antagonist oral anticoagulants and antiplatelet therapy|non-vitamin K  oral anticoagulants and dual antiplatelet therapy|oral anticoagulants and non-vitamin K antagonist oral antcoagulants,2000000075|36675125|2000000070|4294169|2000000071|2000000072|2000000073|4253634|4216319|2000000074|2000000076|2000000077|2000000078,ANTITHROMBOTIC AGENTS,atc:B01A,21600961,,,,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
Diuretica,diuretics,str,,Furosemide=Furosemide|Bumetanide=Bumetanide|nvt=Not applicable|HCTZ=Hydrochlorothiazide|Gestopt ivm bijwerkingen=Discontinued due to side effects|Triamtereen=Triamterene|Contraindicatie=Contraindicated,999|7,11332,,,,,,rxnorm:4603|rxnorm:1808|snomed:385432009|rxnorm:5487|snomed:395009001|rxnorm:10763|snomed:410536001,furosemide|bumetanide|not applicable|hydrochlorothiazide|medication stopped - side effect|triamterene|contraindicated,956874|932745|4294169|974166|4216319|904542|4253634,diuretics,atc:C03,21601461,,,,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DoseringDiuretica,diuretics: dosage,str,mg (miligram),,,11332,,,,,,,,,diuretics,atc:C03,21601461,Dosage,snomed:260911001,4118853,milligram,ucum:mg,8576,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DosisDiuretica,diuretic: daily dosage (no unit),float,,,,11332,,0.5,1040,,,,,,diuretics,atc:C03,21601461,Dosage,snomed:260911001,4118853,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DosisfrequentieDiuretica,diuretic:daily frequency,int,,1=once a day|2=twice a day,,11332,,1=ja|0=nee4,120,,,loinc:LA13827-3|loinc:LA13840-6,1 time per day|2 times per day,45885250|45883167,diuretics,atc:C03,21601461,Dosage|frequency per day,snomed:260911001|snomed:307438009,4118853|4145077,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DagdosisDiuretica,diuretic: total daily dosage,int,,,,11332,,0,1500,,,,,,diuretics,atc:C03,21601461,Dosage|total,snomed:260911001|snomed:255619001,4118853|4112438,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
Furosemide_equivalent,diuretics dose expressed in an amount equivalent to Furosemide,int,mg (miligram),,,11332,,0,9600,,,,,,diuretics,atc:C03,21601461,furosemide,rxnorm:4603,956874,milligram,ucum:mg,8576,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
Statines,statin therapy,str,,simvastatine=Simvastatin|nvt=Not applicable|atorvastatine=Atorvastatin|rosuvastatine=Rosuvastatin|pravastatine=Pravastatin|gestopt ivm bijwerkingen=Discontinued due to side effects|ezetimibe/simvastatine=Ezetimibe/Simvastatin combination|fluvastatine=Fluvastatin|contraindicatie=Contraindicated,,11332,,,,,,rxnorm:36567|rxnorm:83367|rxnorm:301542|rxnorm:42463|snomed:395009001|rxnorm:476348|rxnorm:41127|snomed:410536001,simvastatin|atorvastatin|rosuvastatin|pravastatin|medication stopped - side effect|ezetimibe / simvastatin oral tablet|fluvastatin|contraindicated,1539403|1545958|1510813|1551860|4216319|40054620|1549686|4253634,hmg-coa reductase inhibitor,atc:C10AA,21601855,,,,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
Statine,statin therapy:Medication administered,int,,1=yes|0=no,,11332,,0,1,,,snomed:738990001|loinc:LA4706-3,"administer|""not administered, unknown reason""",42538098|45876430,hmg-coa reductase inhibitor,atc:C10AA,21601855,Medication administration,loinc:LP207306-4,706336,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DoseringStatines,statin: daily dosage,str,mg (miligram),,,11332,,,,,,,,,hmg-coa reductase inhibitor,atc:C10AA,21601855,Dosage,snomed:260911001,4118853,milligram,ucum:mg,8576,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DosisStatines,statin: daily dosage (no unit),float,,,,11332,,5,100,,,,,,hmg-coa reductase inhibitor,atc:C10AA,21601855,Dosage|total,snomed:260911001|snomed:255619001,4118853|4112438,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DosisfrequentieStatines,statins: daily frequency,int,,,9999,11332,,1,9999,,,,,,hmg-coa reductase inhibitor,atc:C10AA,21601855,Dosage|frequency per day,snomed:260911001|snomed:307438009,4118853|4145077,per 24 hours,ucum:/(24.h),44777556,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
ACE,Angiotensin-converting enzyme inhibitor,str,,nvt=Not applicable|perindopril=Perindopril|lisinopril=Lisinopril|ramipril=Ramipril|gestopt ivm bijwerkingen=Discontinued due to side effects|quinapril=Quinapril|enalapril=Enalapril|fosinopril=Fosinopril|contraindicatie=Contraindicated|captopril=Captopril|trandolapril=Trandolapril|zofenopril=Zofenopril,,11332,,,,,,snomed:385432009|rxnorm:54552|rxnorm:29046|rxnorm:35296|snomed:395009001|rxnorm:35208|rxnorm:3827|rxnorm:50166|snomed:410536001|rxnorm:1998|rxnorm:38454|rxnorm:39990,not applicable|perindopril|lisinopril|ramipril|medication stopped - side effect|quinapril|enalapril|fosinopril|contraindicated|captopril|trandolapril|zofenopril,4294169|1373225|1308216|1334456|4216319|1331235|1341927|1363749|4253634|1340128|1342439|19102107,ACE inhibitors plain,atc:C09AA,21601784,,,,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
ACEinhibitor,Angiotensin-converting enzyme:Medication administered,int,,1=yes|0=no,,11332,,0,1,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,ACE inhibitors plain,atc:C09AA,21601784,Medication administration,loinc:LP207306-4,706336,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
ACE_contra,angiotensin-converting enzyme inhibitors: contraindications,int,,1=yes|0=no,,11332,,0,1,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,ACE inhibitors plain,atc:C09AA,21601784,contraindicated,snomed:410536001,4253634,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DoseringACE,Angiotensin-Converting Enzyme drug:dosage,str,mg (miligram),,,11332,,,,,,,,,ACE inhibitors plain,atc:C09AA,21601784,Dosage,snomed:260911001,4118853,milligram,ucum:mg,8576,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DosisACE,Angiotensin-Converting Enzyme inhibitors: daily dosage (no unit),float,,,,11332,,0.625,9999,,,,,,ACE inhibitors plain,atc:C09AA,21601784,Dosage,snomed:260911001,4118853,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DagdosisACE,Angiotensin-Converting Enzyme inhibitors:total daily dosage,float,mg (miligram),,,11332,,0,9999,,,,,,ACE inhibitors plain,atc:C09AA,21601784,Dosage|total,snomed:260911001|snomed:255619001,4118853|4112438,milligram,ucum:mg,8576,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
ACEDose,Angiotensin-converting enzyme: Percentage of target dose,float,percent ,,,11332,,0,400,,,,,,ACE inhibitors plain,atc:C09AA,21601784,Fractionated dose,Snomed:47501000087100,1244023,percent,ucum:%,8554,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
ARB,Angiotensin II Receptor Blockers,str,,nvt=Not applicable|valsartan=Valsartan|losartan=Losartan|irbesartan=Irbesartan|candesartan=Candesartan|telmisartan=Telmisartan|olmesartan=Olmesartan|gestopt ivm bijwerkingen=Discontinued due to side effects|contraindica,,11332,,,,,,snomed:385432009|rxnorm:69749|rxnorm:52175|rxnorm:83818|rxnorm:214354|rxnorm:73494|snomed:395009001|snomed:410536001|rxnorm:321064,not applicable|valsartan|losartan|irbesartan|candesartan|telmisartan|medication stopped - side effect|contraindicated|olmesartan,4294169|1308842|1367500|1347384|1351557|1317640|4216319|4253634|40226742,"""Angiotensin II receptor blockers (ARBs), plain""",atc:C09CA,21601823,,,,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
ARB01,Angiotensin II Receptor Blockers: Medication administered,int,,1=yes|0=no,,11332,,0,1,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Angiotensin II receptor blockers (ARBs) plain,atc:C09CA,21601823,Medication administration,loinc:LP207306-4,706336,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
ARB_contra,Angiotensin II Receptor Blockers: Contraindicated?,int,,1=yes|0=no,,11332,,0,1,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Angiotensin II receptor blockers (ARBs) plain,atc:C09CA,21601823,contraindicated,snomed:410536001,4253634,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DoseringARB,Dosage of Angiotensin II Receptor Blockers: dosage,str,mg (miligram),,,11332,,,,,,,,,Angiotensin II receptor blockers (ARBs) plain,atc:C09CA,21601823,Dosage,snomed:260911001,4118853,milligram,ucum:mg,8576,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DosisARB,Angiotensin II Receptor Blockers inhibitors daily dosage (no unit),float,,,,11332,,2,340,,,,,,Angiotensin II receptor blockers (ARBs) plain,atc:C09CA,21601823,Dosage|frequency per day,snomed:260911001|snomed:307438009,4118853|4145077,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DosisfrequentieARB,Angiotensin II Receptor Blockers inhibitors: daily dose frequency,int,,1=once a day|2=twice a day|3=three times a day,,11332,,1,3,,,loinc:LA13827-3|loinc:LA13840-6|loinc:LA13851-3,1 time per day|2 times per day|3 times per day,45885250|45883167|45883169,Angiotensin II receptor blockers (ARBs) plain,atc:C09CA,21601823,Dosage|total,snomed:260911001|snomed:255619001,4118853|4112438,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DagdosisARB,Angiotensin II Receptor Blockers inhibitors: total daily dosage,float,mg (miligram),,,11332,,0,600,,,,,,Angiotensin II receptor blockers (ARBs) plain,atc:C09CA,21601823,,,,milligram,ucum:mg,8576,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
Renineremmer,Renin-inhibitorss:Medication administered,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Renin-inhibitors,atc:C09XA,21601849,Medication administration,loinc:LP207306-4,706336,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DoseringRenineremmer,Renin-inhibitors: dosage,str,,,,11332,,,,,,,,,Renin-inhibitors,atc:C09XA,21601849,Dosage,snomed:260911001,4118853,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DosisRenineremmer,Renin-inhibitors : daily dosage (no unit),float,,,,11332,,150,300,,,rxnorm:1011736|rxnorm:1011739,aliskiren 150 MG Oral Tablet|aliskiren 300 MG Oral Tablet,40226387|40226406,Renin-inhibitors,atc:C09XA,21601849,Dosage,snomed:260911001,4118853,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DosisfrequentieRenineremmer,Renin-inhibitors:daily dose frequency,int,,,,11332,,1,2,,,,,,Renin-inhibitors,atc:C09XA,21601849,Dosage|frequency per day,snomed:260911001|snomed:307438009,4118853|4145077,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DagdosisRenineremmer,Renin-inhibitors inhibitors:total daily dose,int,mg (miligram),,,11332,,0,300,,,,,,Renin-inhibitors,atc:C09XA,21601849,Dosage|total,snomed:260911001|snomed:255619001,4118853|4112438,milligram,ucum:mg,8576,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
Betablocker,Beta blocking agent,str,,,,11332,,,,,,,,,beta blocking agents,atc:C07A,21601665,,,,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
BB,Beta blocking agent:Medication administered,int,,1=yes|0=no,,11332,,0,1,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,BETA BLOCKING AGENTS,atc:C07A,21601665,Medication administration,loinc:LP207306-4,706336,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
BB_excl_sotalol,Beta blocking agent except sotalol:Medication administered,int,,1=yes|0=no,,11332,,0,1,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,BETA BLOCKING AGENTS,atc:C07A,21601665,Medication administration|Except for|sotalol,loinc:LP207306-4|snomed:5185003|rxnorm:9947,706336|4198066|1370109,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
Sotalol,sotalol:Medication administered,int,,1=yes|0=no,,11332,,0,1,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,sotalol,rxnorm:9947,1370109,Medication administration,loinc:LP207306-4,706336,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
BB_contra,Beta blocking agent:contraindication?,int,,1=yes|0=no,,11332,,0,1,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,BETA BLOCKING AGENTS,atc:C07A,21601665,contraindicated,snomed:410536001,4253634,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DoseringBblocker,Beta blocking agent therapy :daily dosage,str,mg (miligram),,,11332,,,,,,,,,BETA BLOCKING AGENTS,atc:C07A,21601665,Dosage,snomed:260911001,4118853,milligram,ucum:mg,8576,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DosisBblocker,Beta blocking agent:daily dosage (no unit),float,,,,11332,,1,400,,,,,,BETA BLOCKING AGENTS,atc:C07A,21601665,Dosage,snomed:260911001,4118853,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DosisfrequentieBblocker,Beta blocking agent : dosing frequency,int,,1=once a day|2=twice a day|3=three times a day,,11332,,1,3,,,loinc:LA13827-3|loinc:LA13840-6|loinc:LA13851-3,1 time per day|2 times per day|3 times per day,45885250|45883167|45883169,BETA BLOCKING AGENTS,atc:C07A,21601665,Dosage|frequency per day,snomed:260911001|snomed:307438009,4118853|4145077,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DagdosisBblocker,Beta blocking agent:total daily dose,float,,,,11332,,0,800,,,,,,BETA BLOCKING AGENTS,atc:C07A,21601665,Dosage|total,snomed:260911001|snomed:255619001,4118853|4112438,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
BBDose,Beta blocking agent: Percentage of dose,float,percent ,,,11332,,0,2000,,,,,,BETA BLOCKING AGENTS,atc:C07A,21601665,Fractionated dose,Snomed:47501000087100,1244023,percent,ucum:%,8554,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
MRA,Mineralocorticoid Receptor Antagonists,str,,nvt=Not applicable|spironolactone=spironolactone| gestopt ivm bijw=medication stopped due to side effects| contraindicatie=contraindicated,,11332,,,,,,snomed:385432009|rxnorm:9997|rxnorm:298869|snomed:395009001|snomed:410536001,not applicable|spironolactone|eplerenone|medication stopped - side effect|contraindicated,4294169|970250|1309799|4216319|4253634,Aldosterone antagonists,atc:C03DA,21601533,Medication administration,loinc:LP207306-4,706336,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
MRA01,Mineralocorticoid Receptor Antagonists:Medication administered,int,,1=yes|0=no,,11332,,0,1,,,loinc:29303-5|loinc:LA4706-3,"medication administered|not administered, unknown reason",3025263|45876430,Aldosterone antagonists,atc:C03DA,21601533,Medication administration,loinc:LP207306-4,706336,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
MRA_contra,Mineralocorticoid Receptor Antagonists:contraindication ?,int,,1=yes|0=no,,11332,,0,1,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Aldosterone antagonists,atc:C03DA,21601533,contraindicated,snomed:410536001,4253634,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DoseringMRA,Mineralocorticoid Receptor Antagonists : dosage,str,mg (miligram),,,11332,,,,,,,,,Aldosterone antagonists,atc:C03DA,21601533,Dosage,snomed:260911001,4118853,milligram,ucum:mg,8576,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DosisMRA,Mineralocorticoid Receptor Antagonists: daily dosage (no unit),float,,,,11332,,3125,200,,,,,,Aldosterone antagonists,atc:C03DA,21601533,Dosage,snomed:260911001,4118853,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DosisfrequentieMRA,Mineralocorticoid Receptor Antagonists:daily frequency,int,,,,11332,,0.42,3,,,,,,Aldosterone antagonists,atc:C03DA,21601533,Dosage|frequency per day,snomed:260911001|snomed:307438009,4118853|4145077,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DagdosisMRA,Mineralocorticoid Receptor Antagonists: total daily dose,float,,,,11332,,0,200,,,,,,Aldosterone antagonists,atc:C03DA,21601533,Dosage|total,snomed:260911001|snomed:255619001,4118853|4112438,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
MRADose,Mineralocorticoid Receptor Antagonists: Percentage of dose,float,percent ,,,11332,,0,200,,,,,,Aldosterone antagonists,atc:C03DA,21601533,Fractionated dose,Snomed:47501000087100,1244023,percent,ucum:%,8554,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
Digoxine,Digoxine:Medication administered,str,,nvt=not applicable| digoxine=digixon| gestopt ivm bijw=stopped| contraindicatie=contrainidicated,,11332,,,,,,snomed:385432009|rxnorm:3407|snomed:395009001|snomed:410536001,not applicable|digoxin|medication stopped - side effect|contraindicated,4294169|1326303|4216319|4253634,digoxin,rxnorm:3407,1326303,Medication administration,loinc:LP207306-4,706336,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DoseringDigoxine,Digoxin: dosage,str,mg (miligram),,,11332,,,,,,,,,digoxin,rxnorm:3407,1326303,Dosage,snomed:260911001,4118853,milligram,ucum:mg,8576,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DosisDigoxine,Digoxine:daily dosage (no unit),float,,,,11332,,0.0165,0.625,,,,,,digoxin,rxnorm:3407,1326303,Dosage,snomed:260911001,4118853,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DosisfrequentieDigoxine,Digoxine: dosing frequency,int,,,,11332,,1,1,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,digoxin,rxnorm:3407,1326303,Dosage|frequency per day,snomed:260911001|snomed:307438009,4118853|4145077,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DagdosisDigoxine,Digoxine: total daily dose,float,,,,11332,,0,0.625,,,,,,digoxin,rxnorm:3407,1326303,Dosage|total,snomed:260911001|snomed:255619001,4118853|4112438,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
Amiodarone,Amiodarone,str,,nvt=Not applicable|amiodarone=amiodarone| gestopt ivm bijw=medication stopped due to side effects| contraindicatie=contraindicated,,11332,,,,,,snomed:385432009|rxnorm:703|snomed:395009001|snomed:410536001,not applicable|amiodarone|medication stopped - side effect|contraindicated,4294169|1309944|4216319|4253634,amiodarone,rxnorm:703,1309944,,,,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DoseringAmiodarone,Amiodarone: dosage,str,mg (miligram),,,11332,,,,,,loinc:LA13827-3|loinc:LA13840-6|loinc:LA13851-3,1 time per day|2 times per day|3 times per day,45885250|45883167|45883169,amiodarone,rxnorm:703,1309944,Dosage,snomed:260911001,4118853,milligram,ucum:mg,8576,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DosisAmiodarone,Amiodarone:Daily dose,float,,,,11332,,50,400,,,,,,amiodarone,rxnorm:703,1309944,Dosage,snomed:260911001,4118853,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DosisfrequentieAmiodarone,Amiodarone:dosing frequency,int,,1=once a day|2=twice a day|3=three times a day,,11332,,1,3,,,loinc:LA13827-3|loinc:LA13840-6|loinc:LA13851-3,1 time per day|2 times per day|3 times per day,45885250|45883167|45883169,amiodarone,rxnorm:703,1309944,Dosage|frequency per day,snomed:260911001|snomed:307438009,4118853|4145077,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DagdosisAmiodarone,Amiodarone:total daily dose,float,,,,11332,,0,600,,,,,,amiodarone,rxnorm:703,1309944,Dosage|total,snomed:260911001|snomed:255619001,4118853|4112438,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
ARNI,Angiotensin Receptor Neprilysin Inhibitor,str,,,,11332,,,,,,,,,Renin-inhibitors,atc:C09XA,21601849,,,,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DoseringARNI,Angiotensin Receptor Neprilysin Inhibitor: dosage,float,,,,11332,,,,,,,,,Renin-inhibitors,atc:C09XA,21601849,Dosage,snomed:260911001,4118853,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
IJzerstatus,iron deficiency status,str,,nvt=not applicable|Ferritine 100-300ug/l +transferrine saturatie<20%=functional iron deficiency|Ferritine <100ug/l=absolute iron deficiency,,11332,,,,,,snomed:385432009|snomed:40143009|snomed:56136002,not applicable|Functional|Absolute,40480274|4222447|4210327,Iron deficiency screening,snomed:171198002,4064375,,,,,,,observation,baseline,40766819,Baseline time,loinc:64103-5
ACEroptimaal,Optimization of drug dose of Angiotensin-converting enzyme inhibitor therapy,str,,nvt=Not applicable| max verdraagbaar=Maximum tolerated dose| targetdosis=target dose| titratiefase=Titration phase| contraindicatie=contraindicated,,11332,,,,,,snomed:385432009|snomed:407566003|snomed:108741000000109|snomed:494716691000132104|snomed:410536001,not applicable|patient on maximum tolerated dose|Angiotensin converting enzyme inhibitor target dose achieved|Medication titrated|contraindicated,4294169|4232917|44787827|37304212|4253634,"""ACE inhibitors, plain""",atc:C09AA,21601784,Optimization of drug dosage,snomed:395067002,4191838,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
ARBoptimaal,optimization of drug dosage Angiotensin II Receptor Blockers inhibitor therapy,str,,nvt=Not applicable| max verdraagbaar=Maximum tolerated dose| targetdosis=target dose| titratiefase=Titration phase| contraindicatie=contraindicated,,11332,,,,,,snomed:385432009|snomed:407566003|icare:icv200000066|snomed:494716691000132104|snomed:410536001,not applicable|patient on maximum tolerated dose|Angiotensin II receptor blocker target dose achieved|Medication titrated|contraindicated,4294169|4232917|2000000066|37304212|4253634,"""Angiotensin II receptor blockers (ARBs), plain""",atc:C09CA,21601823,Optimization of drug dosage,snomed:395067002,4191838,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
BBoptimaal,optimization of drug dose of Beta-Blocker therapy,str,,nvt=Not applicable| max verdraagbaar=Maximum tolerated dose| targetdosis=target dose| titratiefase=Titration phase| contraindicatie=contraindicated,,11332,,,,,,snomed:385432009|snomed:407566003|snomed:88641000000105|snomed:494716691000132104|snomed:410536001,not applicable|patient on maximum tolerated dose|Beta blocker target dose achieved|Medication titrated|contraindicated,4294169|4232917|44810174|37304212|4253634,BETA BLOCKING AGENTS,atc:C07A,21601665,optimization of drug dosage,snomed:395067002,4191838,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
MRAoptimaal,optimization of drug dose of Mineralocorticoid Receptor Antagonists therapy,str,,nvt=Not applicable| max verdraagbaar=Maximum tolerated dose| targetdosis=target dose| titratiefase=Titration phase| contraindicatie=contraindicated,,11332,,,,,,snomed:385432009|snomed:407566003|icare:icv200000069|snomed:494716691000132104|snomed:410536001,not applicable|patient on maximum tolerated dose|Mineralocorticoid Receptor Antagonists target dose achieved|Medication titrated|contraindicated,4294169|4232917|2000000069|37304212|4253634,Aldosterone antagonists,atc:C03DA,21601533,optimization of drug dosage,snomed:395067002,4191838,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
Extrainformatiemedicatie,Other drugs indicated during treatment plan,str,,,,11332,,,,,,,,,other therapeutic products,atc:V03AX,21605291,,,,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
Interventie,surgical Intervention performed during treatment plan,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,surgical procedure,snomed:387713003,4301351,,,,,,,procedure_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Devices,medical devices used in intervention,str,,nvt=Not applicable|ICD=Implantable Cardioverter-Defibrillator| CRT-D=Cardiac Resynchronization Therapy with Defibrillator| Pacemaker=pacemaker|CRT-P=Cardiac Resynchronization Therapy with Pacemaker|Overwogen nvt in dossier=not applicable or not indicated|Mitraclip=Mitraclip|LVAD=Left Ventricular Assist Device,,11332,,,,,,loinc:LA137-2|snomed:1236894001|snomed:704707009|loinc:LA19767-5|snomed:704708004|snomed:385661002|snomed:459691000124101|loinc:LA9994-0,none|subcutaneous implantable cardioverter defibrillator|cardiac resynchronization therapy implantable defibrillator|pacemaker|cardiac resynchronization therapy implantable pacemaker|considered and not done|Transcatheter mitral valve repair|left ventricular assistive device (lvad),45878582|37164898|45767328|36310218|45767329|4294902|36684977|45883988,biomedical device,snomed:63653004,4272314,health intervention,snomed:718771000000107,44804044,,,,device_exposure,baseline,40766819,Baseline time,loinc:64103-5
Datumplaatsing,Date of intervention,DATETIME,dd/mm/yyyy,,,11332,,,,,,,,,date of procedure,snomed:439272007,4232096,health intervention,snomed:718771000000107,44804044,,,,procedure_occurrence,baseline,40766819,Baseline time,loinc:64103-5
DatumEvents,Date of Event,DATETIME,dd/mm/yyyy,,,11332,,,,,,,,,date of event,snomed:439771001,4208903,,,,,,,observation,baseline,40766819,Baseline time,loinc:64103-5
Telemonitoring,Telehealth monitoring,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,telehealth monitoring,snomed:719858009,36714564,,,,,,,procedure_occurrence,baseline,40766819,Baseline time,loinc:64103-5
IngebruikzijndeSysteem,monitoring system used,str,,,,11332,,,,,,,,,physiologic monitoring system,snomed:5159002,4197813,,,,,,,device_exposure,baseline,40766819,Baseline time,loinc:64103-5
Schildklier,Thyroid gland Finding,str,,,,11332,,,,,,,,,thyroid gland observable,snomed:364388004,4270271,,,,,,,observation,baseline,40766819,Baseline time,loinc:64103-5
Anemie,Anemia,str,,,,11332,,,,,,,,,anemia,snomed:271737000,439777,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
GFR,Glomerular Filtration Rate measurement,str,,,,11332,,,,,,,,,Glomerular filtration rate,snomed:80274001,4213477,,,,,,,measurement,baseline,40766819,Baseline time,loinc:64103-5
NTproBNP,N-terminal pro b-type natriuretic peptide in blood,str,pmol/L,,,11332,,,,,,,,,n terminal pro-brain natriuretic peptide level,snomed:414799001,4189511,blood,loinc:LA17759-4,45878416,picomole per liter,ucum:pmol/L,8729,measurement,baseline,40766819,Baseline time,loinc:64103-5
pmol,N terminal pro-brain natriuretic peptide level,int,,1=yes|0=no,,11332,,0,1,,,loinc:LA6112-2|loinc:LA6111-4,yes|no,45878303|45880618,n terminal pro-brain natriuretic peptide level,snomed:414799001,4189511,,,,,,,measurement,baseline,40766819,Baseline time,loinc:64103-5
pgml,N terminal pro-brain natriuretic peptide level,int,pg/ml,1=yes|0=no,,11332,,0,1,,,loinc:LA6112-2|loinc:LA6111-4,yes|no,45878303|45880618,n terminal pro-brain natriuretic peptide level,snomed:414799001,4189511,,,,picogram per milliliter,ucum:pg/mL,8845,measurement,baseline,40766819,Baseline time,loinc:64103-5
NTBNP_raw,N terminal pro-brain natriuretic peptide level,int,,,,11332,,2,100000,,,,,,n terminal pro-brain natriuretic peptide level,snomed:414799001,4189511,,,,,,,measurement,baseline,40766819,Baseline time,loinc:64103-5
NTBNP,N terminal pro-brain natriuretic peptide level,int,,,,11332,,2,234452.4,,,,,,n terminal pro-brain natriuretic peptide level,snomed:414799001,4189511,,,,,,,measurement,baseline,40766819,Baseline time,loinc:64103-5
BNP,Natriuretic peptide.B prohormone N-Terminal in Serum or Plasma,str,,,,11332,,,,,,,,,Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma,loinc:33762-6,3029187,,,,,,,measurement,baseline,40766819,Baseline time,loinc:64103-5
VitamineD,Vitamin D,str,,,,11332,,,,,,,,,vitamin d,rxnorm:11253,19009405,,,,,,,measurement,baseline,40766819,Baseline time,loinc:64103-5
Ischemiedetectie_Nvt,ischemia detection: not applicable,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,ischemic heart disease screening,snomed:171223006,4064926,,,,,,,procedure_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Ischemiedetectie_Ergometrie,An exercise stress test was performed for ischemia detection,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,exercise stress echocardiography,snomed:433233004,4335824,ischemic heart disease screening,snomed:171223006,4064926,,,,procedure_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Ischemiedetectie_Myocardscintigrafie,myocardial perfusion scintigraphy:ischemia detection,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,referral for radionuclide myocardial perfusion study,snomed:429711002,4330793,myocardial ischemia,Snomed:414795007,4306655,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Ischemiedetectie_CTcoronairen,CT coronary angiography for ischemia detection,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,ct angiography of coronary artery with contrast,snomed:419545005,4306317,ischemic heart disease screening,snomed:171223006,4064926,,,,procedure_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Ischemiedetectie_CAG,Coronary Angiography for ischemia detection,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Angiography of coronary artery,snomed:33367005,4142645,ischemic heart disease screening,snomed:171223006,4064926,,,,procedure_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Ischemiedetectie_mristressecho,Magnetic resoce imaging (MRI) for ischemia detection,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,magnetic resonance imaging,snomed:113091000,4013636,ischemic heart disease screening,snomed:171223006,4064926,,,,procedure_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Ischemisch,ischemia,int,,1=yes|0=no,,11332,,0,1,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,ischemia,snomed:52674009,4200991,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Ischemisch_CMP,Ischemic cardiomyopathy,int,,1=yes|0=no,,11332,,0,1,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,ischemic dilated cardiomyopathy due to coronary artery disease,snomed:472100003,43020660,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Non_ischemisch_CMP,Cardiomyopathy,int,,1=yes|0=no,,11332,,0,1,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,cardiomyopathy,snomed:85898001,321319,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
OorzaakHF_onbekend,is reason of heart failure known?,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,heart failure,snomed:84114007,316139,,,,,,,observation,baseline,40766819,Baseline time,loinc:64103-5
OorzaakHF_Ischemischinfarct,is heart failure related to ischemic infarct?,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Myocardial infarction,snomed:22298006,4329847,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
OorzaakHF_IschemischCMP,is heart failure related to cardiomyopathy?,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Ischemic myocardial dysfunction,Snomed:281091000,4092936,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
OorzaakHFischemisch,is heart failure related to ischemic conditions?,int,,1=yes|0=no,,11332,,0,1,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Ischemic heart disease,Snomed:414545008,4185932,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
OorzaakHF_NonIschemischCMP,is heart failure related to non cardiomyopathy?,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Nonischemic cardiomyopathy ,icare:icv2000000047,2000000047,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
OorzaakHF_HypertensieCMP,is heart failure related to Hypertensive Cardiomyopathy (CMP)?,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,cardiomyopathy due to hypertension,snomed:108701000119102,36712757,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
OorzaakHF_OverigeCMP,is heart failure related to other Cardiomyopathy (CMP)?,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,cardiomyopathy,snomed:85898001,321319,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
OorzaakHF_Kleplijden,is heart failure related to valvular heart disease?,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Heart valve disorder,Snomed:368009,4281749,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
OorzaakHF_Boezemfibrillerenflutter,Is heart failure related to Atrial Fibrillation or Atrial Flutter?,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Atrial fibrillation,Snomed:49436004,313217,atrial flutter,snomed:5370000,314665,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
OorzaakHF_Overigeritmestoornissen,Is heart failure is attributed to arrhythmias,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Cardiac arrhythmia,Snomed:698247007,44784217,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
OorzaakHF_ImpulsGeleiding,Is heart failure is associated with or by impulse conduction disorder- pacemaker is giving worse heart function?,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,conduction disorder of the heart,Snomed:44808001,316999,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
OorzaakHF_Overig,heart failure cause not specified,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,heart failure,snomed:84114007,316139,unknown (origin),snomed:54690008,4185231,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Comorbiditeit_Nvt,are there no applicable commodities or additional conditions present?,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,comorbidities and coexisting conditions,loinc:83243-6,36204549,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Comorbiditeit_Anemie,Anemia,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,anemia,snomed:271737000,439777,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Comorbiditeit_HT,hypertension,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,hypertension,loinc:LA7444-8,45876622,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Comorbiditeit_DM1,Diabetes Mellitus Type 1 (DM1),str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,type 1 diabetes mellitus,snomed:46635009,201254,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Comorbiditeit_DM2,Diabetes Mellitus Type 2 (DM2),str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,type 2 diabetes mellitus,snomed:44054006,201826,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Comorbiditeit_COPD,Chronic Obstructive Pulmonary Disease (COPD) finding status,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,chronic obstructive pulmonary disease monitoring status,snomed:201341000000101,44788836,,,,,,,observation,baseline,40766819,Baseline time,loinc:64103-5
Comorbiditeit_OSAS,Obstructive Sleep Apnea Syndrome,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,obstructive sleep apnea syndrome,snomed:78275009,442588,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Comorbiditeit_Hypercholesterolemie,hypercholesterolemia as a comorbid condition,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,hypercholesterolemia,snomed:13644009,4029305,co-morbid conditions,snomed:398192003,4160039,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Comorbiditeit_Nierfalen,kidney failure (renal failure),str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,renal failure syndrome,snomed:42399005,192359,renal failure syndrome,snomed:42399005,192359,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Nierfalen_eGFR,Glomerular filtration rate testing,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Estimated creatinine clearance calculated using actual body weight Cockcroft-Gault formula,Snomed:1556501000000100,37169169,,,,,,,measurement,baseline,40766819,Baseline time,loinc:64103-5
Comorbiditeit_Vaatlijden,perpherial artiary disease,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,peripheral arterial disease,snomed:840580004,3654996,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
interventie_Geen,Surgical/procedural intervention performed,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Surgical/procedural intervention,loinc:LA21145-0,45878223,,,,,,,procedure_occurrence,baseline,40766819,Baseline time,loinc:64103-5
interventie_PCI,Percutaneous Coronary Intervention performed,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,percutaneous coronary intervention performed,loinc:80727-1,21493696,,,,,,,procedure_occurrence,baseline,40766819,Baseline time,loinc:64103-5
interventie_Klepok,Surgical intervention indicated,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,surgical intervention indicated,snomed:360751000000100,44803204,,,,,,,procedure_occurrence,baseline,40766819,Baseline time,loinc:64103-5
interventie_CABG,Coronary Artery Bypass Grafting (CABG) performed,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,coronary artery bypass graft,snomed:232717009,4336464,,,,,,,procedure_occurrence,baseline,40766819,Baseline time,loinc:64103-5
interventie_Ander,surgical/procedure Intervention performed,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,surgical procedure,snomed:387713003,4301351,,,,,,,procedure_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Hartrevalidatie_Nvt,cardiac rehabilitation not applicable,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,cardiac rehabilitation,snomed:313395003,4209116,,,,,,,observation,baseline,40766819,Baseline time,loinc:64103-5
Hartrevalidatie_Continueondersteuningthuis,continuous home support is part of rehabilitation program,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,rehabilitation therapy,snomed:52052004,4180248,home support,snomed:304351000000106,44791820,,,,procedure_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Hartrevalidatie_Ergotherapie,Seen by dietitian in cardiac rehabilitation,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,seen by dietitian,snomed:185284002,4088553,cardiac rehabilitation,snomed:313395003,4209116,,,,visit,baseline,40766819,Baseline time,loinc:64103-5
Hartrevalidatie_Fysiotherapie,Seen by occupational therapy service as part of the cardiac rehabilitation program,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,occupational therapy service,snomed:310093001,4147252,cardiac rehabilitation programme offered,snomed:1103751000000101,36685875,,,,visit,baseline,40766819,Baseline time,loinc:64103-5
Hartrevalidatie_Psychologie,Seen by physiotherapy as part of cardiac rehabilitation program,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,physiotherapy,snomed:722138006,36716213,cardiac rehabilitation programme offered,snomed:1103751000000101,36685875,,,,visit,baseline,40766819,Baseline time,loinc:64103-5
Ritme_AF,Atrial Fibrillation finding status,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,atrial fibrillation,snomed:49436004,313217,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
Events_Op,Admitted in hospital,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Emergency hospital admission for heart failure,Snomed:416683003,4215511,,,,,,,observation,baseline,40766819,Baseline time,loinc:64103-5
Events_Herop,Patient Readmission,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Emergency hospital admission for heart failure,Snomed:416683003,4215511,readmission,loinc:LA4395-5,36210471,,,,visit,baseline,40766819,Baseline time,loinc:64103-5
Events_Overleden,Patient status determination| deceased/dead,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,death,Snomed:419620001,4306655,,,,,,,death,baseline,40766819,Baseline time,loinc:64103-5
Jaar_DatumeersteHFpolibezoek,baseline visit to Heart Failure Clinic,DATETIME,dd/mm/yyyy,,,11332,,,,,,,,,seen in heart failure clinic,snomed:416717003,4220132,baseline time,loinc:64103-5,40766819,,,,visit,baseline,40766819,Baseline time,loinc:64103-5
Jaar_DatumHF,Diagnosis confirmed for heart failure,DATETIME,dd/mm/yyyy,,,11332,,,,,,,,,heart failure,snomed:84114007,316139,disorder confirmed,snomed:395098000,4194404,,,,observation,baseline,40766819,Baseline time,loinc:64103-5
Jaar_DatumEvents,Date of enrollment in heart failure registry,DATETIME,dd/mm/yyyy,,,11332,,,,,,,,,enrollment in clinical trial,snomed:709491003,46271379,heart failure review completed,snomed:202231000000106,44789102,,,,visit,baseline,40766819,Baseline time,loinc:64103-5
DiureticumYN,Diuretics:Medication administered,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,diuretics,atc:C03,21601461,Medication administration,loinc:LP207306-4,706336,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
StatineYN,statins therapy:Medication administered,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,hmg-coa reductase inhibitor,snomed:734592007,42536020,Medication administration,loinc:LP207306-4,706336,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
ACEYN,Angiotensin-converting enzyme inhibitor:Medication administered,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,ACE inhibitors plain,atc:C09AA,21601784,Medication administration,loinc:LP207306-4,706336,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
ARBYN,Angiotensin II Receptor inhibitor:Medication administered,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Angiotensin II receptor blockers (ARBs) plain,atc:C09CA,21601823,Medication administration,loinc:LP207306-4,706336,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
BetablockerYN,Beta blocking agent:Medication administered,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,BETA BLOCKING AGENTS,atc:C07A,21601665,Medication administration,loinc:LP207306-4,706336,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
ACEorARBYN,"ACE and ATR2, Medication administered",str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Renin-inhibitors,atc:C09XA,21601849,Medication administration,loinc:LP207306-4,706336,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
ACEenARBYN,"ACE or ATR2, Medication administered",str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Renin-inhibitors,atc:C09XA,21601849,Medication administration,loinc:LP207306-4,706336,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
CHECKHF1ekeer,Initial assessment for heart failure,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,initial patient assessment,loinc:LA21589-9,21498504,heart failure,loinc:LP269425-7,1177390,,,,observation,baseline,40766819,Baseline time,loinc:64103-5
CHECKHF2ekeer,Follow-up cardiac assessment,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,follow-up cardiac assessment,snomed:170572009,4017167,,,,,,,visit,baseline,40766819,Baseline time,loinc:64103-5
AFYN,Atrial Fibrillation finding status,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,atrial fibrillation,snomed:49436004,313217,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
MRAYN,Mineralocorticoid Receptor Antagonist,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,Aldosterone antagonists,atc:C03DA,21601533,,,,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
IfremmerYN,ivabradina,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,ivabradine,rxnorm:1649480,46234437,,,,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DigoxineYN,digoxin,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,digoxin,rxnorm:3407,1326303,,,,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
AmiodaroneYN,Amiodarone,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,amiodarone,rxnorm:703,1309944,,,,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
ARNIYN,Angiotensin Receptor Neprilysin Inhibitor medication,str,,ja=yes|nee=no,,11332,,,,,,loinc:LA33-6|loinc:LA32-8,yes|no,45877994|45878245,valsartan and sacubitril,oral,atc:C09DX04,drug_exposure,,,,,,1588648,baseline,40766819,Baseline time,loinc:64103-5
RenineremmerYN,Renin-inhibitors:Medication administered,str,,,,11332,,,,,,,,,Renin-inhibitors,atc:C09XA,21601849,Medication administration,loinc:LP207306-4,706336,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
filter_$,Heart failure confirmed,str,,,,11332,,,,,,,,,heart failure confirmed,snomed:395105005,4215689,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
interventies,total medical interventions performed,int,,1=only once|0=No|2=two interventions| 3=three interventions|4=four interventions,,11332,,0,4,,,,,,number of medications [minimum data set],loinc:45833-1,3043339,,,,,,,measurement,baseline,40766819,Baseline time,loinc:64103-5
HFmrEF_obv_beginEF,Patient has Heart Failure with mid range ejection fractionn (HFmrEF): baseline time,str,,HFpEF=Heart Failure with preserved Ejection Fraction| HFrEF=Heart Failure with reduced Ejection Fraction| HfmrEF=Heart Failure with mid range Ejection Fraction,,11332,,,,,,snomed:446221000|snomed:703272007|snomed:788950000,heart failure with normal ejection fraction|heart failure with reduced ejection fraction|heart failure with mid range ejection fraction,40486933|45766164|37311948,heart failure with mid range ejection fraction,snomed:788950000,37311948,baseline time,loinc:64103-5,40766819,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
HFmrEF_obv_EFNu,Assessment of Heart Failure with mid range Ejection Fraction (HfmrEF),str,,HFpEF=Heart failure with preserved ejection fraction| HFrEF=Heart failure with reduced ejection fraction| HfmrEF=Heart failure with mig range ejection fraction,,11332,,,,,,snomed:446221000|snomed:703272007|snomed:788950000,heart failure with normal ejection fraction|heart failure with reduced ejection fraction|heart failure with mid range ejection fraction,40486933|45766164|37311948,heart failure with mid range ejection fraction,snomed:788950000,37311948,,,,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
HFpEF_BMI,Body Mass Index (BMI) for patients diagnosed with Heart Failure with preserved Ejection Fraction (HFpEF) is determined,str,,BMI 25-30=overweight| BMI>30=obesity| BMI<25=normal or underweight,,11332,,,,,,snomed:43664005|snomed:238131007|snomed:414915002,normal weight|overweight|obese,4183890|437525|4215968,body mass index,snomed:60621009,4245997,heart failure,snomed:84114007,316139,,,,measurement,baseline,40766819,Baseline time,loinc:64103-5
HFpEF_SRvsHFpEF_AF,Atrial flutter diagnosis,str,,HFpEF + SR=patient with HFpEF who also has sinus rythm| HFpEF + AF=patient with HFpEF who also has Atrial Fibrillation| 2=both,,11332,,,,,,snomed:446221000|snomed:446221000,heart failure with normal ejection fraction|heart failure with normal ejection fraction,40486933|40486933,atrial flutter,snomed:5370000,314665,diagnosis|heart failure with normal ejection fraction|sinus rhythm|atrial fibrillation,snomed:439401001|snomed:446221000|snomed:251150006|snomed:49436004,4234469|40486933|4091898|313217,,,,condition_occurrence,baseline,40766819,Baseline time,loinc:64103-5
timeevent,time of event,int,,,,11332,,,,,,,,,time of event,snomed:460791000124109,37208123,,,,,,,visit,baseline,40766819,Baseline time,loinc:64103-5
Ifremmer,ivabradina:Medication administered,str,,nvt=not applicable|ivabradina=ivabradina| gestopt ivm bijw=Stopped due to side effects|contraindicatie=contraindicated,,,,,,,,snomed:385432009|rxnorm:1649480|snomed:395009001|snomed:410536001,not applicable|ivabradine|medication stopped - side effect|contraindicated,4294169|46234437|4216319|4253634,ivabradine,rxnorm:1649480,46234437,Medication administration,loinc:LP207306-4,706336,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DoseringIfremmer,ivabradina: dosage,str,mg (miligram),,,,,,,,,,,,ivabradine,rxnorm:1649480,46234437,Dosage,snomed:260911001,4118853,milligram,ucum:mg,8576,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DosisIfremmer,ivabradina: daily dosage (no unit),float,,,,,,,,,,,,,ivabradine,rxnorm:1649480,46234437,Dosage,snomed:260911001,4118853,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DosisfrequentieIfremmer,Ivabradina: dosing frequency,int,,1=once a day|2=twice a day,,,,,,,,loinc:LA13827-3|loinc:LA13840-6,1 time per day|2 times per day,45885250|45883167,ivabradine,rxnorm:1649480,46234437,Dosage|frequency per day,snomed:260911001|snomed:307438009,4118853|4145077,,,,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
DagdosisIfremmer,ivabradina total daily dose,float,mg (miligram),,,,,,,,,,,,ivabradine,rxnorm:1649480,46234437,Dosage|total,snomed:260911001|snomed:255619001,4118853|4112438,milligram,ucum:mg,8576,drug_exposure,baseline,40766819,Baseline time,loinc:64103-5
